A Cell Line–based Immunohistochemical p53 Expression Pattern Control Panel

Imran Hussain, Robin S. Howard, Viqar Syed, Michael Allgäuer, Heping Gong, Deyin Xing, John D. Andersen

Research output: Contribution to journalArticle

Abstract

TP53 gene mutations are known to manifest in distinct p53 immunohistochemical staining patterns; overexpression, wild-type, and null. These stratified staining patterns are routinely utilized in subtyping ovarian cancer subtypes. Three ovarian cancer cell lines were used in the construction of an immunohistochemical p53 expression pattern control panel that highlight respective TP53 mutation status. The cell line control panel sections demonstrated consistent clean and easily interpretable p53 immunohistochemical staining. Procured resection, biopsy, and cytologic specimens were submitted along with either standard control tissue or a p53 cell line control panel to pathologists of varying experience for interrater reliability analysis. Individual interrater reliability was near-perfect and was improved with the p53 cell line control panel when compared with the tissue control. The cell line control panel demonstrated decreased misinterpretation of null expression pattern as wild-type. Next-generation sequencing analysis was performed on the cell lines and select cases, in which there was discordance in p53 expression pattern interpretation. Next-generation sequencing analysis demonstrated low-frequency variant mutations in some cases in which there was reviewer discordance. This study suggests the addition of a p53 cell line expression pattern control panel could potentially increase p53 interpretation accuracy for ovarian cancer subtypes. We developed a cell line–based p53 control panel that has the potential to increase individual interrater reliability for p53 immunohistochemical expression pattern determination, support immunohistochemical optimization, and direct submission of difficult to interpret p53 staining cases to next-generation sequencing.

Original languageEnglish (US)
JournalInternational Journal of Gynecological Pathology
DOIs
StateAccepted/In press - Jul 18 2018

Fingerprint

Cell Line
Ovarian Neoplasms
Staining and Labeling
Mutation
p53 Genes
Mutation Rate
Biopsy

Keywords

  • Cell line
  • Control panel
  • Immunohistochemistry
  • Next-generation sequencing
  • P53
  • TP53

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Obstetrics and Gynecology

Cite this

A Cell Line–based Immunohistochemical p53 Expression Pattern Control Panel. / Hussain, Imran; Howard, Robin S.; Syed, Viqar; Allgäuer, Michael; Gong, Heping; Xing, Deyin; Andersen, John D.

In: International Journal of Gynecological Pathology, 18.07.2018.

Research output: Contribution to journalArticle

Hussain, Imran ; Howard, Robin S. ; Syed, Viqar ; Allgäuer, Michael ; Gong, Heping ; Xing, Deyin ; Andersen, John D. / A Cell Line–based Immunohistochemical p53 Expression Pattern Control Panel. In: International Journal of Gynecological Pathology. 2018.
@article{197ee35e855d45d590a2bd3881a0f415,
title = "A Cell Line–based Immunohistochemical p53 Expression Pattern Control Panel",
abstract = "TP53 gene mutations are known to manifest in distinct p53 immunohistochemical staining patterns; overexpression, wild-type, and null. These stratified staining patterns are routinely utilized in subtyping ovarian cancer subtypes. Three ovarian cancer cell lines were used in the construction of an immunohistochemical p53 expression pattern control panel that highlight respective TP53 mutation status. The cell line control panel sections demonstrated consistent clean and easily interpretable p53 immunohistochemical staining. Procured resection, biopsy, and cytologic specimens were submitted along with either standard control tissue or a p53 cell line control panel to pathologists of varying experience for interrater reliability analysis. Individual interrater reliability was near-perfect and was improved with the p53 cell line control panel when compared with the tissue control. The cell line control panel demonstrated decreased misinterpretation of null expression pattern as wild-type. Next-generation sequencing analysis was performed on the cell lines and select cases, in which there was discordance in p53 expression pattern interpretation. Next-generation sequencing analysis demonstrated low-frequency variant mutations in some cases in which there was reviewer discordance. This study suggests the addition of a p53 cell line expression pattern control panel could potentially increase p53 interpretation accuracy for ovarian cancer subtypes. We developed a cell line–based p53 control panel that has the potential to increase individual interrater reliability for p53 immunohistochemical expression pattern determination, support immunohistochemical optimization, and direct submission of difficult to interpret p53 staining cases to next-generation sequencing.",
keywords = "Cell line, Control panel, Immunohistochemistry, Next-generation sequencing, P53, TP53",
author = "Imran Hussain and Howard, {Robin S.} and Viqar Syed and Michael Allg{\"a}uer and Heping Gong and Deyin Xing and Andersen, {John D.}",
year = "2018",
month = "7",
day = "18",
doi = "10.1097/PGP.0000000000000537",
language = "English (US)",
journal = "International Journal of Gynecological Pathology",
issn = "0277-1691",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - A Cell Line–based Immunohistochemical p53 Expression Pattern Control Panel

AU - Hussain, Imran

AU - Howard, Robin S.

AU - Syed, Viqar

AU - Allgäuer, Michael

AU - Gong, Heping

AU - Xing, Deyin

AU - Andersen, John D.

PY - 2018/7/18

Y1 - 2018/7/18

N2 - TP53 gene mutations are known to manifest in distinct p53 immunohistochemical staining patterns; overexpression, wild-type, and null. These stratified staining patterns are routinely utilized in subtyping ovarian cancer subtypes. Three ovarian cancer cell lines were used in the construction of an immunohistochemical p53 expression pattern control panel that highlight respective TP53 mutation status. The cell line control panel sections demonstrated consistent clean and easily interpretable p53 immunohistochemical staining. Procured resection, biopsy, and cytologic specimens were submitted along with either standard control tissue or a p53 cell line control panel to pathologists of varying experience for interrater reliability analysis. Individual interrater reliability was near-perfect and was improved with the p53 cell line control panel when compared with the tissue control. The cell line control panel demonstrated decreased misinterpretation of null expression pattern as wild-type. Next-generation sequencing analysis was performed on the cell lines and select cases, in which there was discordance in p53 expression pattern interpretation. Next-generation sequencing analysis demonstrated low-frequency variant mutations in some cases in which there was reviewer discordance. This study suggests the addition of a p53 cell line expression pattern control panel could potentially increase p53 interpretation accuracy for ovarian cancer subtypes. We developed a cell line–based p53 control panel that has the potential to increase individual interrater reliability for p53 immunohistochemical expression pattern determination, support immunohistochemical optimization, and direct submission of difficult to interpret p53 staining cases to next-generation sequencing.

AB - TP53 gene mutations are known to manifest in distinct p53 immunohistochemical staining patterns; overexpression, wild-type, and null. These stratified staining patterns are routinely utilized in subtyping ovarian cancer subtypes. Three ovarian cancer cell lines were used in the construction of an immunohistochemical p53 expression pattern control panel that highlight respective TP53 mutation status. The cell line control panel sections demonstrated consistent clean and easily interpretable p53 immunohistochemical staining. Procured resection, biopsy, and cytologic specimens were submitted along with either standard control tissue or a p53 cell line control panel to pathologists of varying experience for interrater reliability analysis. Individual interrater reliability was near-perfect and was improved with the p53 cell line control panel when compared with the tissue control. The cell line control panel demonstrated decreased misinterpretation of null expression pattern as wild-type. Next-generation sequencing analysis was performed on the cell lines and select cases, in which there was discordance in p53 expression pattern interpretation. Next-generation sequencing analysis demonstrated low-frequency variant mutations in some cases in which there was reviewer discordance. This study suggests the addition of a p53 cell line expression pattern control panel could potentially increase p53 interpretation accuracy for ovarian cancer subtypes. We developed a cell line–based p53 control panel that has the potential to increase individual interrater reliability for p53 immunohistochemical expression pattern determination, support immunohistochemical optimization, and direct submission of difficult to interpret p53 staining cases to next-generation sequencing.

KW - Cell line

KW - Control panel

KW - Immunohistochemistry

KW - Next-generation sequencing

KW - P53

KW - TP53

UR - http://www.scopus.com/inward/record.url?scp=85051058088&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051058088&partnerID=8YFLogxK

U2 - 10.1097/PGP.0000000000000537

DO - 10.1097/PGP.0000000000000537

M3 - Article

C2 - 30028355

AN - SCOPUS:85051058088

JO - International Journal of Gynecological Pathology

JF - International Journal of Gynecological Pathology

SN - 0277-1691

ER -